EP3699181
Kristallað form af (s)-n-(5-((r)-2-(2,5-díflúorófenýl)-pýrrólídín-1-ýl)-pýrasóló[1,5-a]pýrimídín-3-ýl)-3-hýdroxýpýrrólídín-1-karboxamíð hýdrógensúlfati
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.11.2015EP published:
1.3.2023EP application number:
20169707.5
EP translation filed:
16.3.2023Grant published:
15.4.2023EPO information:
European Patent Register
Max expiry date:
15.11.2035Expiry date:
15.11.2026Next due date:
30.11.2026
Title in English:
CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATELanguage of the patent:
English
Timeline
Today
16.11.2015EP application
1.3.2023EP Publication
16.3.2023Translation submitted
15.4.2023Registration published
15.11.2026Expires
Owner
Name:
Array Biopharma, Inc.Address:
3200 Walnut Street, Boulder, CO 80301, US
Inventor
Name:
ARRIGO, Alisha B.Address:
Boulder, CO 80301, US
Name:
JUENGST, DerrickAddress:
Boulder, CO 80301, US
Name:
SHAH, KhalidAddress:
South San Francisco, CA 94080, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462080374 PDate:
16.11.2014Country:
US
Number:
201562169545 PDate:
1.6.2015Country:
US
Classification
Categories:
C07D 487/04, A61K 31/519, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.11.2023
Expires: 15.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.11.2023
Expires: 15.11.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.10.2024
Expires: 15.11.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.11.2025
Expires: 15.11.2026
Payer: Árnason Faktor ehf.